[1]
Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. The Lancet. Infectious diseases. 2014 Sep:14(9):813-9. doi: 10.1016/S1473-3099(14)70805-9. Epub 2014 Aug 4
[PubMed PMID: 25104307]
Level 2 (mid-level) evidence
[2]
Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PloS one. 2018:13(6):e0198772. doi: 10.1371/journal.pone.0198772. Epub 2018 Jun 11
[PubMed PMID: 29889859]
Level 1 (high-level) evidence
[3]
Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical microbiology reviews. 2010 Jul:23(3):467-92. doi: 10.1128/CMR.00070-09. Epub
[PubMed PMID: 20610819]
[4]
Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. JAMA pediatrics. 2019 Mar 1:173(3):224-233. doi: 10.1001/jamapediatrics.2018.4826. Epub
[PubMed PMID: 30640366]
[5]
Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Le Doare K, Rubens CE, Saha SK, Sobanjo-Ter Meulen A, Vekemans J, Schrag S, Infant GBS Disease Investigator Group. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Nov 6:65(suppl_2):S160-S172. doi: 10.1093/cid/cix656. Epub
[PubMed PMID: 29117326]
Level 1 (high-level) evidence
[6]
Birlutiu V, Birlutiu RM, Costache VS. Viridans streptococcal infective endocarditis associated with fixed orthodontic appliance managed surgically by mitral valve plasty: A case report. Medicine. 2018 Jul:97(27):e11260. doi: 10.1097/MD.0000000000011260. Epub
[PubMed PMID: 29979391]
Level 3 (low-level) evidence
[7]
Lucas MJ, Brouwer MC, Bovenkerk S, Man WK, van der Ende A, van de Beek D. Group A Streptococcal meningitis in adults. The Journal of infection. 2015 Jul:71(1):37-42. doi: 10.1016/j.jinf.2015.01.008. Epub 2015 Jan 20
[PubMed PMID: 25614959]
[8]
van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. The New England journal of medicine. 2004 Oct 28:351(18):1849-59
[PubMed PMID: 15509818]
[9]
Lucht F. [Sensitivity and specificity of clinical signs in adults]. Medecine et maladies infectieuses. 2009 Jul-Aug:39(7-8):445-51. doi: 10.1016/j.medmal.2009.06.015. Epub 2009 Jul 24
[PubMed PMID: 19632074]
[10]
Østergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC infectious diseases. 2005 Oct 27:5():93
[PubMed PMID: 16253143]
[11]
Thomas KE, Hasbun R, Jekel J, Quagliarello VJ. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002 Jul 1:35(1):46-52
[PubMed PMID: 12060874]
[12]
Ku LC, Boggess KA, Cohen-Wolkowiez M. Bacterial meningitis in infants. Clinics in perinatology. 2015 Mar:42(1):29-45, vii-viii. doi: 10.1016/j.clp.2014.10.004. Epub 2014 Dec 6
[PubMed PMID: 25677995]
[13]
Amarilyo G, Alper A, Ben-Tov A, Grisaru-Soen G. Diagnostic accuracy of clinical symptoms and signs in children with meningitis. Pediatric emergency care. 2011 Mar:27(3):196-9. doi: 10.1097/PEC.0b013e31820d6543. Epub
[PubMed PMID: 21346676]
[14]
Weber MW, Herman J, Jaffar S, Usen S, Oparaugo A, Omosigho C, Adegbola RA, Greenwood BM, Mulholland EK. Clinical predictors of bacterial meningitis in infants and young children in The Gambia. Tropical medicine & international health : TM & IH. 2002 Sep:7(9):722-31
[PubMed PMID: 12225501]
[15]
Ma JS, Chen PY, Mak SC, Chi CS, Lau YJ. Clinical outcome of invasive pneumococcal infection in children: a 10-year retrospective analysis. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2002 Mar:35(1):23-8
[PubMed PMID: 11950116]
Level 2 (mid-level) evidence
[16]
Mohammadi SF, Patil AB, Nadagir SD, Nandihal N, Lakshminarayana SA. Diagnostic value of latex agglutination test in diagnosis of acute bacterial meningitis. Annals of Indian Academy of Neurology. 2013 Oct:16(4):645-9. doi: 10.4103/0972-2327.120491. Epub
[PubMed PMID: 24339598]
[17]
Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology. 2010 Oct 26:75(17):1533-9. doi: 10.1212/WNL.0b013e3181f96297. Epub 2010 Sep 29
[PubMed PMID: 20881273]
[18]
de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. The New England journal of medicine. 2002 Nov 14:347(20):1549-56
[PubMed PMID: 12432041]
[19]
Romain AS, Cohen R, Plainvert C, Joubrel C, Béchet S, Perret A, Tazi A, Poyart C, Levy C. Clinical and Laboratory Features of Group B Streptococcus Meningitis in Infants and Newborns: Study of 848 Cases in France, 2001-2014. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018 Mar 5:66(6):857-864. doi: 10.1093/cid/cix896. Epub
[PubMed PMID: 29045606]
Level 3 (low-level) evidence
[20]
Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain : a journal of neurology. 2003 May:126(Pt 5):1015-25
[PubMed PMID: 12690042]
Level 3 (low-level) evidence
[21]
Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics. 2013 Sep:132(3):421-8. doi: 10.1542/peds.2013-0621. Epub 2013 Aug 26
[PubMed PMID: 23979090]
[22]
Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, Cooper T, Sparks RC, Baker CJ, Shah PE. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012 Jul:130(1):e8-15. doi: 10.1542/peds.2011-3453. Epub 2012 Jun 11
[PubMed PMID: 22689869]
[23]
Falkenhorst G, Remschmidt C, Harder T, Hummers-Pradier E, Wichmann O, Bogdan C. Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. PloS one. 2017:12(1):e0169368. doi: 10.1371/journal.pone.0169368. Epub 2017 Jan 6
[PubMed PMID: 28061505]
Level 1 (high-level) evidence
[24]
Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, Riley ID, Makela H. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. The Cochrane database of systematic reviews. 2009 Oct 7:2009(4):CD004977. doi: 10.1002/14651858.CD004977.pub2. Epub 2009 Oct 7
[PubMed PMID: 19821336]
Level 1 (high-level) evidence
[25]
Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, Patton M, McDonough A, Moradoghli-Haftvani A, Smith H, Mellelieu T, Pride MW, Crowther G, Schmoele-Thoma B, Scott DA, Jansen KU, Lobatto R, Oosterman B, Visser N, Caspers E, Smorenburg A, Emini EA, Gruber WC, Grobbee DE. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. The New England journal of medicine. 2015 Mar 19:372(12):1114-25. doi: 10.1056/NEJMoa1408544. Epub
[PubMed PMID: 25785969]
[26]
. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782. Obstetrics and gynecology. 2019 Jul:134(1):1. doi: 10.1097/AOG.0000000000003334. Epub
[PubMed PMID: 31241599]
Level 3 (low-level) evidence
[27]
Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013 Aug 28:31 Suppl 4():D20-6. doi: 10.1016/j.vaccine.2012.11.056. Epub 2012 Dec 3
[PubMed PMID: 23219695]